Schriesheim, Germany

Alfred Martens


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Alfred Martens: Pioneering Indoline Compounds

Introduction: Alfred Martens, an inventive mind hailing from Schriesheim, Germany, has made significant contributions to the field of pharmaceuticals through his innovative work in chemical compounds. As a key inventor at Boehringer Mannheim GmbH, Martens holds a patent that could revolutionize the treatment of heart and circulatory diseases.

Latest Patents: Alfred Martens is credited with a notable patent focused on indoline compounds. His invention, which provides indolines of a particular formula, is crucial for synthesizing pharmaceutically active pyrrolobenzimidazoles, or their tautomers. These compounds are particularly valuable in addressing heart or circulatory diseases, especially those that require adjustments in blood pressure, enhancement of cardiac output, or modifications in micro-circulation.

Career Highlights: Throughout his career, Martens has dedicated himself to advancing pharmaceutical chemistry. His patent stands out as an essential breakthrough that underscores his commitment to improving health outcomes through high-quality research and innovation.

Collaborations: Martens has had the opportunity to work alongside esteemed colleagues such as Jens-Peter Holck and Herbert Berger. This collaborative environment at Boehringer Mannheim GmbH fosters a culture of innovation and excellence, leading to impactful discoveries.

Conclusion: Alfred Martens exemplifies the spirit of innovation in the pharmaceutical industry. With his patented indoline compounds, he plays a pivotal role in developing treatments for serious health conditions. His work not only contributes to scientific knowledge but also holds the promise of improving the quality of life for many patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…